Journal article

Safety evaluation of the food enzyme β-galactosidase from the genetically modified Bacillus licheniformis strain DSM 34099


Authors listEFSA FEZ Panel; Zorn, Holger; Barat Baviera, José Manuel; Bolognesi, Claudia; Catania, Francesco; Gadermaier, Gabriele; Greiner, Ralf; Mayo, Baltasar; Mortensen, Alicja; Roos, Yrjö Henrik; Solano, Marize LM; Sramkova, Monika; Van Loveren, Henk; Vernis, Laurence; Roos, Yrjö; Andryszkiewicz, Magdalena; Cavanna, Daniele; Kovalkovicova, Natalia; Peluso, Silvia; de Sousa, Rita Ferreira

Publication year2024

JournalEFSA Journal

Volume number22

Issue number8

eISSN1831-4732

DOI Linkhttps://doi.org/10.2903/j.efsa.2024.8949

PublisherWiley


Abstract
The food enzyme beta-galactosidase (beta-d-galactoside galactohydrolase; EC 3.2.1.23) is produced with the genetically modified Bacillus licheniformis strain DSM 34099 by Kerry Group Services International, Ltd. (KGSI). The genetic modifications do not give rise to safety concerns. The food enzyme is free from viable cells of the production organism and its DNA. The production strain met the requirements for the qualified presumption of safety (QPS) approach. The food enzyme is intended to be used in two food manufacturing processes. Dietary exposure was estimated to be up to 7.263 mg total organic solids/kg body weight per day in European populations. Given the QPS status of the production strain and the absence of concerns resulting from the food enzyme manufacturing process, toxicity tests, other than an assessment of allergenicity, were considered unnecessary by the Panel. A search for the identity of the amino acid sequence of the food enzyme to known allergens was made and one match with a food allergen from kiwi fruit was found. The Panel considered that a risk of allergic reactions upon dietary exposure to this food enzyme, particularly in individuals sensitised to kiwi fruit, cannot be excluded. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns, under the intended conditions of use.



Authors/Editors




Citation Styles

Harvard Citation styleEFSA FEZ Panel, Zorn, H., Barat Baviera, J., Bolognesi, C., Catania, F., Gadermaier, G., et al. (2024) Safety evaluation of the food enzyme β-galactosidase from the genetically modified Bacillus licheniformis strain DSM 34099, EFSA Journal, 22(8), Article e8949. https://doi.org/10.2903/j.efsa.2024.8949

APA Citation styleEFSA FEZ Panel, Zorn, H., Barat Baviera, J., Bolognesi, C., Catania, F., Gadermaier, G., Greiner, R., Mayo, B., Mortensen, A., Roos, Y., Solano, M., Sramkova, M., Van Loveren, H., Vernis, L., Roos, Y., Andryszkiewicz, M., Cavanna, D., Kovalkovicova, N., Peluso, S., ...de Sousa, R. (2024). Safety evaluation of the food enzyme β-galactosidase from the genetically modified Bacillus licheniformis strain DSM 34099. EFSA Journal. 22(8), Article e8949. https://doi.org/10.2903/j.efsa.2024.8949


Last updated on 2025-21-05 at 17:28